Project Grant HT94252410705

Award Date 9/1/24
Completion Date 8/31/27
Dollars Obligated $565K
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
San Francisco, CA 94103, USA
Similar Awards
This Federal Project Grant award for $236,777.00 was provided by the Defense Health Agency to The Regents of the University of California, San Francisco (UCSF) under the Military Medical Research and Development program (CFDA 12.420). The funding supports RAPID HIGH RESOLUTION METABOLIC IMAGING FOR IMPROVED MANAGEMENT OF PATIENTS WITH GLIOMA, a research project aimed at developing advanced imaging techniques to better manage patients with glioma, a type of brain cancer. The award term runs...
This federal Project Grant award of $1,041,595.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award supports advanced biomedical research focused on transforming healthcare for military service members and the broader public. The grant funds The Regents of the University of California, San Francisco (UCSF) to conduct research across multiple medical disciplines, including cancer research, neuroscience, rare diseases,...
The Defense Health Agency awarded a $1,453,500.00 Project Grant to The Regents of the University of California, San Francisco (UCSF) under the Military Medical Research and Development program (CFDA 12.420). This 3-year grant, commencing on June 20, 2023, will support UCSF's research to profile and eliminate tumor subclones resistant to radioligand therapy. Through this project, UCSF aims to transform health care for Service Members and the American public by developing innovative and...
This Project Grant award for $901,906 from the Defense Health Agency supports research to develop "AUTOMATIC RAPID, HIGH RESOLUTION METABOLIC IMAGING FOR IMPROVED MANAGEMENT OF PATIENTS WITH GLIOMA". The funding is provided through the Military Medical Research and Development program (CFDA 12.420) which focuses on biomedical research to address military and veteran health needs. The research, conducted by the Regents of the University of California, San Francisco (UCSF), aims to...
This federal Project Grant award of $1,008,313.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will support advanced biomedical research by The Regents of the University of California, San Francisco (UCSF). The award, effective September 1, 2024 through August 31, 2027, will fund UCSF's research focused on transforming healthcare for military service members and the broader public. The research aims to advance disease prevention,...
The Regents of the University of California, San Francisco (UCSF) has been awarded a $499,985 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a 2-year research project titled "DIET, EXERCISE, AND INFLAMMATION IN EARLY-STAGE NEURONAL ALPHA-SYNUCLEIN DISEASE" to investigate novel approaches for treating neurodegenerative disorders relevant to military personnel and the broader population. As a...
The University of California, San Francisco (UCSF) has been awarded a $726,745 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on June 1, 2024, will support a 3-year research project to investigate "DISSECTING RAS GAP SPECIFICITY IN THE PERIPHERAL NERVOUS SYSTEM". The research aims to advance the understanding of key cellular signaling mechanisms involved in the peripheral nervous system, with...
This Project Grant award, valued at $592,500.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports the development of a "Mutant DNA-Activated Killing System for Precision Breast Cancer Therapy" at the University of California, San Diego (UC San Diego). The research aims to advance innovative biomedical solutions for military service members and the broader public. UC San Diego, a leading...
This federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) provides $1,292,000.00 to the University of California, San Francisco (UCSF) to conduct in vivo mechanistic characterization of the angiogenic immune checkpoint in liver cancer. The research aims to transform healthcare for Service Members and the American public through innovative and impactful biomedical investigations. The 4-year research project will involve...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $1,453,501.00 Project Grant to The Regents of the University of California, San Francisco (UCSF) on June 1, 2024. The grant supports the development of "Targeted Theranostic Nanopolymers for Imaging and Alpha Radiopharmaceutical Therapy of Prostate Cancer" over a period of 3 years through May 31, 2027. As a leading academic medical center, UCSF will leverage its expertise in biomedical...

This federal Project Grant award in the amount of $565,250 was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "ATP CITRATE LYASE AS A DRUGGABLE VULNERABILITY IN MUTANT ISOCITRATE DEHYDROGENASE GLIOMAS", will support research conducted by The Regents of the University of California, San Francisco (UCSF) from September 1, 2024 through August 31, 2027. The research aims to investigate ATP citrate lyase as a potential therapeutic target for gliomas with mutant isocitrate dehydrogenase, which are a type of brain cancer commonly affecting military personnel. This grant award represents UCSF's ongoing partnership with federal agencies like the DHA to advance innovative medical research and deliver healthcare solutions for the military and broader public.

Generated 4/8/25, 4:56 AM